Agreement for depression diagnosis between DSM-IV-Tr criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer

Clinical Interventions in Aging

Volumn 10, Issue , 2015, Pages 1155-1162

  Rhondali, Wadih ^a   Freyer, Gilles ^b   Adam, Virginie ^c   Filbet, Marilène ^b   Derzelle, Martine ^d   Abgrall Barbry, Gaelle ^e   Bourcelot, Sophie ^f   Machavoine, Jean Louis ^g   Chomat Neyraud, Muriel ^h   Gisserot, Olivier ⁱ   Largillier, Rémi ^j   Le Rol, Annick ^k   Priou, Frank ^l   Saltel, Pierre ^f   Falandry, Claire ^b  

^a Clinique Mon Repos   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CRLCC de Lorraine Alexis Vautrin   (France)

^d INSTITUT JEAN GODINOT   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f CENTRE LÉON BÉRARD   (France)

^g CENTRE FRANÇOIS BACLESSE   (France)

^h Centre Hospitalier de la Region d'Annecy   (France)

ⁱ Military Teaching Hospital Sainte Anne   (France)

^j Centre Azureen de Cancerologie   (France)

^k Hôpital Perpétuel Secours   (France)

^l Medical Oncology   (France)

more..

Author keywords

Cancer; Depression; Elderly; Geriatric assessment; Screening

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DSM-IV; FALSE NEGATIVE RESULT; FEMALE; GERIATRIC DEPRESSION SCALE; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ANXIETY DEPRESSION SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL THERMOMETER; MONTGOMERY ASBERG DEPRESSION RATING SCALE; ONCOLOGIST ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PREDICTIVE VALUE; PSYCHIATRIC CLINICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; SELF REPORT; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GERIATRIC ASSESSMENT; MORTALITY; ONCOLOGY; OVARY TUMOR; PROCEDURES; PSYCHOLOGY; REPRODUCIBILITY; STANDARDS;

AGED; AGED, 80 AND OVER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INTERVIEWS AS TOPIC; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY;

EID: 84937408898     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S71690     Document Type: Article

References (59)

1. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174.
2. Bellera CA, Rainfray M, Mathoulin-Pélissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–2172.
3. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–2107.
4. Block S. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians – American Society of Internal Medicine. Ann Intern Med. 2000;132(3):209–218.
5. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004;52(1):106–111.
6. Weinberger MI, Bruce ML, Roth AJ, Breitbart W, Nelson CJ. Depression and barriers to mental health care in older cancer patients. Int J Geriatr Psychiatry. 2011;26(1):21–26.
7. Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression – an independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009;113(1–2):127–132.
8. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349–5361.
9. Pirl WF, Traeger L, Greer JA, et al. Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer. Palliat Support Care. 2013;11(3):223–229.
10. Rayner L, Price A, Evans A, Valsraj K, Hotopf M, Higginson IJ. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med. 2011;25(1):36–51.
11. Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer. 2011;47(5):702–712.
12. Evans M, Mottram P. Diagnosis of depression in elderly patients. Adv Psychiatr Treat. 2000;6:49–56.
13. Söllner W, DeVries A, Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84(2):179–185.
14. Little L, Dionne B, Eaton J. Nursing assessment of depression among palliative care cancer patients. J Hosp Palliat Nurs. 2005;7(2):98–106.
15. Klap R, Unroe KT, Unützer J. Caring for mental illness in the United States: a focus on older adults. Am J Geriatr Psychiatry. 2003;11(5):517–524.
16. Morley JE. The top 10 hot topics in aging. J Gerontol A Biol Sci Med Sci. 2004;59(1):24–33.
17. Flaherty JH, McBride M, Marzouk S, et al. Decreasing hospitalization rates for older home care patients with symptoms of depression. J Am Geriatr Soc. 1998;46(1):31–38.
18. Nelson CJ, Cho C, Berk AR, Holland J, Roth AJ. Are gold standard depression measures appropriate for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples. J Clin Oncol. 2010;28(2):348–356.
19. Weinberger MI, Roth AJ, Nelson CJ. Untangling the complexities of depression diagnosis in older cancer patients. Oncologist. 2009;14(1):60–66.
20. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol. 1998;16(4):1594–1600.
21. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374(9690):609–619.
22. Mitchell AJ, Rao S, Vaze A. International comparison of clinicians’ ability to identify depression in primary care: meta-analysis and meta-regression of predictors. Br J Gen Pract. 61(583):e72–e80.
23. Rhondali W, Hui D, Kim SH, et al. Association between patient-reported symptoms and nurses’ clinical impressions in cancer patients admitted to an acute palliative care unit. J Palliat Med. 2012;15(3):301–307.
24. Maguire P. Improving the detection of psychiatric problems in cancer patients. Soc Sci Med. 1985;20(8):819–823.
25. Lloyd-Williams M, Friedman T, Rudd N. A survey of antidepressant prescribing in the terminally ill. Palliat Med. 1999;13(3):243–248.
26. Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81–97.
27. Yennurajalingam S, Kwon JH, Urbauer DL, Hui D, Reyes-Gibby CC, Bruera E. Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center. Palliat Support Care. 2013;11(6):473–480.
28. Yennurajalingam S, Urbauer DL, Casper KL, et al. Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage. 2011;41(1):49–56.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). 4th ed. Washington, DC: American Psychiatric Association; 2000.
30. Falandry C, Weber B, Savoye AM, et al. Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Ann Oncol. 2013;24(11):2808–2813.
31. Clément JP, Nassif RF, Léger JM, Marchan F. [Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale]. Encephale. 1997;23(2):91–99. French.
32. Lépine JP, Godchau M, Brun P, Lempérière T. [Evaluation of anxiety and depression among patients hospitalized on an internal medicine service]. Ann Med Psychol (Paris). 1985;143(2):175–189. French.
33. Lepine JP, Godchau M, Brun P. Anxiety and depression in inpatients. Lancet. 1985;2(8469–8470):1425–1426.
34. Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR; Southern European Psycho-Oncology Study Group. Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer. 2005;13(8):600–606.
35. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17(1):37–49.
36. Burke WJ, Nitcher RL, Roccaforte WH, Wengel SP. A prospective evaluation of the Geriatric Depression Scale in an outpatient geriatric assessment center. J Am Geriatr Soc. 1992;40(12):1227–1230.
37. Crawford GB, Robinson JA. The geriatric depression scale in palliative care. Palliat Support Care. 2008;6(3):213–223.
38. Lloyd-Williams M, Spiller J, Ward J. Which depression screening tools should be used in palliative care? Palliat Med. 2003;17(1):40–43.
39. Hegel MT, Collins ED, Kearing S, Gillock KL, Moore CP, Ahles TA. Sensitivity and specificity of the Distress Thermometer for depression in newly diagnosed breast cancer patients. Psychooncology. 2008;17(6):556–560.
40. Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS. Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology. 2008;17(6):621–625.
41. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer. 2005;103(7):1494–1502.
42. Trédan O, Geay JF, Touzet S, et al; Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens. Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens. Ann Oncol. 2007;18(2):256–262.
43. Tison P. [Structured interview guide for evaluating depression in elderly patients, adapted from DSM IV and the GDS, HDRS and MADRS scales]. Encephale. 2000;26(3):33–43. French.
44. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv. 1976;6(3):493–508.
45. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–186.
46. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–919.
47. Cohen ME, Marino RJ. The tools of disability outcomes research functional status measures. Arch Phys Med Rehabil. 2000;81(2 Suppl 12):S21–S29.
48. Donovan KA, Jacobsen PB. Progress in the implementation of NCCN guidelines for distress management by member institutions. J Natl Compr Canc Netw. 2013;11(2):223–226.
49. Holland JC, Bultz BD; National Comprehensive Cancer Network (NCCN). The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw. 2007;5(1):3–7.
50. Jacobsen PB, Ransom S. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw. 2007;5(1):99–103.
51. Stukenberg KW, Dura JR, Kiecolt-Glaser JK. Depression screening scale validation in an elderly, community-dwelling population. Psychol Assess. 1990;2(2):134–138.
52. Jadoon NA, Munir W, Shahzad MA, Choudhry ZS. Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study. BMC Cancer. 2010;10:594.
53. Mackenzie LJ, Carey ML, Sanson-Fisher RW, D’Este CA, Paul CL, Yoong SL. Agreement between HADS classifications and single-item screening questions for anxiety and depression: a cross-sectional survey of cancer patients. Ann Oncol. 2014;25(4):889–895.
54. Colasanti V, Marianetti M, Micacchi F, Amabile GA, Mina C. Tests for the evaluation of depression in the elderly: a systematic review. Arch Gerontol Geriatr. 2010;50(2):227–230.
55. Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol. 2005;16(11):1795–1800.
56. Cosco TD, Doyle F, Ward M, McGee H. Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review. J Psychosom Res. 2012;72(3):180–184.
57. Coyne JC, van Sonderen E. No further research needed: abandoning the Hospital and Anxiety Depression Scale (HADS). J Psychosom Res. 2012;72(3):173–174.
58. Doyle F, Cosco T, Conroy R. Why the HADS is still important: reply to Coyne and van Sonderen. J Psychosom Res. 2012;73(1):77–78.
59. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994;30A(1):37–40.